A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on communication apps, according to recent findings.
Investigational Treatment Gaining Popularity Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a robust trade exists on Telegram, where groups with thousands of participants share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three intestinal hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being hailed online as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and chemists have cautions that the distribution of what remains an unlicensed medication in the United Kingdom is worrisome and could result in individuals administering products of uncertain source.
Some experts said the demand for retatrutide could be linked to the increasing price of licensed slimming products such as Mounjaro.
Legal Position and Implementation
Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and supply can still breach medicines, advertising, and consumer regulations, potentially leading to penalties, legal action or imprisonment.
Platform Response and Material Elimination
According to TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The company said it was committed to maintaining the service safe and allocating resources in enhancing compliance measures.
Digital Trading Operations
Research also discovered groups with up to nine thousand participants selling retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, populated with images of weight loss, positive testimonials and detailed guides for preparing or administering at residence.
Within moments of entering one community, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and promised delivery within two days. When asked whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None inquired about body mass, health issues or past usage.
Item Details and Costs
Within these groups, posts display black plastic parcels with Royal Mail stickers, stating to include fresh supplies. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, mixed at residence with sterile water, or ready-to-use injectors usually sold at 160 pounds for 20mg. When asked how much time a pen should last, vendors give conflicting answers ranging from a few weeks to “depends on your body”.
Service Oversight and Safety Actions
A representative for Telegram said it actively monitored harmful content on its platform including content that encouraged the “misuse of controlled medications”. The company added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital versions may not contain what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But counterfeit treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she explained.
Her staff has previously encountered individuals injured by self-injection from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or communication platforms is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency globally. “Consequently at this point no one can sell [it] for human use,” they said, adding that any item “falsely representing itself as a Lilly experimental product not yet authorized … may expose patients to possibly significant health risks”.
